Another study using a murine model of chronic myelogenous leukemia showed a decreased ENT1 activity reduction following reduced mRNA level of ENT1 [61]. This evidence concerns the gene SLC29A1 and chronic myelogenous leukemia, BCR-ABL1 positive.